CASI Pharmaceuticals (CASI) PT Lowered to $10 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Price: $0.21 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 22 | New: 15
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 22 | New: 15
Join SI Premium – FREE
BTIG analyst Justin Zelin lowered the price target on CASI Pharmaceuticals (NASDAQ: CASI) to $10.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- TeamViewer (TMV:GR) (TMVWY) PT Lowered to EUR6.50 at Deutsche Bank
- Skandinaviska Enskilda Banken AB (SEBA:SS) (SKVKY) PT Lowered to SEK203 at Deutsche Bank
- Stevanato Group S.p.A. (STVN) PT Lowered to $20 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
